NDC 55289-481-60
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-481
- Requested NDC
- 55289-481-60
- Package NDCs from labels
- 55289-481-60
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-481-30 | EA - Each | 55289-481 | 07a64ede-48e8-4037-90d9-a2e69c8fba30 | 1 | 2012-07-24 |
| 55289-481-60 | EA - Each | 55289-481 | 2663740b-cd0e-41c2-a485-f06ffb45344f | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8bd5dce0-d56a-4e64-8de7-e7cd7775526b | 2026-11-02 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | c7a54ee0-80c0-4c7e-a6a3-cb60142f860c | 2026-10-30 | Warnings, Adverse reactions | VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE |
| verapamil hydrochloride | VERAPAMIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | d23c757d-39f8-48c3-ba63-df2cbe58c516 | 2026-10-30 | Warnings, Adverse reactions | verapamil hydrochloride VERAPAMIL HYDROCHLORIDE |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | af1249b0-e889-4f02-bdc2-54862de0545e | 2026-10-30 | Warnings, Adverse reactions | Verapamil Hydrochloride VERAPAMIL HYDROCHLORIDE |
| TROSPIUM CHLORIDE | TROSPIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 6303cf3c-175c-46ff-9b88-05f6ea7a2135 | 2026-10-30 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Triazolam | TRIAZOLAM | PD-Rx Pharmaceuticals, Inc. | f8ca4773-e201-4cb9-8869-5ee07ba1d0bf | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| SILODOSIN | SILODOSIN | PD-Rx Pharmaceuticals, Inc. | 94bca72c-c74a-4181-8b6a-a0a2f654a0a7 | 2026-10-30 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Esomeprazole Magnesium | ESOMEPRAZOLE MAGNESIUM | PD-Rx Pharmaceuticals, Inc. | ac12cd05-10cf-4694-a9e8-e5f04fe162a7 | 2026-10-30 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Chlorthalidone | CHLORTHALIDONE | PD-Rx Pharmaceuticals, Inc. | 08b7ee65-53a5-ffbb-e063-6294a90ad4ee | 2026-10-30 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Estradiol | ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | d0d1c2c8-b175-4250-9343-d7db65b72e8f | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Tenofovir Disoproxil Fumarate | TENOFOVIR DISOPROXIL FUMARATE | PD-Rx Pharmaceuticals, Inc. | 08a30772-02fc-4f63-e063-6394a90afd43 | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | PD-Rx Pharmaceuticals, Inc. | 1522921b-d6c2-420d-ba0d-39ac16ba8b37 | 2026-10-30 | Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2026-10-30 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 270398a0-21b8-407b-af76-4aeef90f72be | 2026-10-29 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| nitrofurantoin macrocrystals | NITROFURANTOIN MACROCRYSTALS | PD-Rx Pharmaceuticals, Inc. | f28d72be-56d7-467f-a3f8-9ffd57d0dffa | 2026-10-29 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Anastrozole | ANASTROZOLE | PD-Rx Pharmaceuticals, Inc. | b023a9f2-1a99-4b40-a953-edac7e3a79bf | 2026-10-29 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| tadalafil | TADALAFIL | PD-Rx Pharmaceuticals, Inc. | 5de70f00-00ac-4656-883e-d1e07d5f71d6 | 2026-10-29 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| FAMOTIDINE | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | a3b50576-cd40-4f7e-9506-bd0a61988424 | 2026-10-29 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0e5a7b02-3972-47f0-9f49-e958d792beac | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.